Table 3.
Pat. no | Pre-GLT (b-OH-b) | Post-GLT (b-OH-b) | Pat. no | Pre-GLT (lactate) | Post-GLT (lactate) |
---|---|---|---|---|---|
1 | 1.45 | 1.82 | 1 | 14 | 19 |
2 | 1.05 | 1.49 | 2 | 10 | 14 |
3 | 1.23 | 1.65 | 3 | 15 | 21 |
4 | 1.45 | 1.88 | 4 | 8 | 10 |
5 | 1.30 | 1.45 | 5 | 10 | 13 |
6 | 1.15 | 1.34 | 6 | 12 | 17 |
7 | 1.35 | 1.42 | 7 | 14 | 18 |
8 | 1.20 | 1.36 | 8 | 14 | 19 |
9 | 1.00 | 1.25 | 9 | 12 | 14 |
10 | 0.90 | 1.10 | 10 | 9 | 12 |
11 | 1.30 | 1.45 | 11 | 8 | 9 |
12 | 1.40 | 1.60 | 12 | 10 | 13 |
13 | 1.25 | 1.35 | 13 | 16 | 35 |
14 | 1.30 | 1.55 | 14 | 15 | 35 |
15 | 1.10 | 1.25 | 15 | 12 | 29 |
16 | 1.35 | 1.45 | 16 | 12 | 34 |
Patients with pathologically increased sera beta-hydroxybutyrate and lactate following glucose loading test (GLT). Patients 13–16 had both increased b-OH-b (beta-hydroxybutyrate) and lactate. Values for b-OH-b are in mmol/L, while those for lactate are in mg/dL. According to the kit employed for measurement of these metabolites, pathological values for b-OH-b pathological are considered >1.5 mmol/L, while pathological levels of lactate are considered as those >15 mg/dL. Pathological results for post-GLT lactate are those that exceed 30% of the pre-GLT lactate value.